EPS Biotechnology (Shenzhen) Co.,Ltd

Was established in 2017 and is animportant strategic layout of EPS Group in the field of medical artificialintelligence. With "AI Cloud Pathology" as its core technology, thecompany has built a comprehensive AI cloud diagnosis service system forcomprehensive products. Provide cervical liquid-based cytology slice digitalscanning and artificial intelligence assisted diagnosis system, pathologicalslice digital scanning and application system, digital pathology remoteconsultation platform and expert diagnostic services and related cytopathologyand molecular pathology diagnostic products.

The company has a top-notch artificialintelligence research and development team and a team of medical experts. Theresearch and development team has nearly 200 people, accounting for 70% of thecompany's total staff, of which doctors and masters account for more than 30%.Set up the Institute of Medical Artificial Intelligence in Canada, andcooperate with top international teams such as Harvard University MedicalSchool and the Royal Academy of Sciences of Canada. Committed to creating a"digital, informatized, and intelligent" pathology service platformfor global medical institutions to provide more valuable and precise servicesfor human health.